This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1986 Sep-Oct;6(5):1020-32.

doi: 10.1002/hep.1840060534.

Genetically determined polymorphisms in drug oxidation

E Jacqz, S D Hall, R A Branch

PMID: 3758933
DOI: 10.1002/hep.1840060534

Genetically determined polymorphisms in drug oxidation

E Jacqz et al. Hepatology. 1986 Sep-Oct.

. 1986 Sep-Oct;6(5):1020-32.

doi: 10.1002/hep.1840060534.

Authors

E Jacqz, S D Hall, R A Branch

PMID: 3758933
DOI: 10.1002/hep.1840060534

No abstract available

PubMed Disclaimer

Similar articles

[Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications].
Eichelbaum M. Eichelbaum M. Internist (Berl). 1983 Mar;24(3):117-27. Internist (Berl). 1983. PMID: 6135670 Review. German. No abstract available.
Polymorphic drug oxidation in humans.
Eichelbaum M. Eichelbaum M. Fed Proc. 1984 May 15;43(8):2298-302. Fed Proc. 1984. PMID: 6714436
Genetic polymorphisms of drug metabolism.
Meyer UA, Zanger UM, Skoda RC, Grant D, Blum M. Meyer UA, et al. Prog Liver Dis. 1990;9:307-23. Prog Liver Dis. 1990. PMID: 2156298 Review. No abstract available.
The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
Meyer UA, Gut J, Kronbach T, Skoda C, Meier UT, Catin T, Dayer P. Meyer UA, et al. Xenobiotica. 1986 May;16(5):449-64. doi: 10.3109/00498258609050251. Xenobiotica. 1986. PMID: 2874666
Genetic polymorphism of drug metabolism in humans.
Gross AS, Kroemer HK, Eichelbaum M. Gross AS, et al. Adv Exp Med Biol. 1991;283:627-40. doi: 10.1007/978-1-4684-5877-0_79. Adv Exp Med Biol. 1991. PMID: 2069031 Review. No abstract available.

See all similar articles

Cited by

Debrisoquine oxidation phenotype during neuroleptic monotherapy.
Spina E, Martines C, Caputi AP, Cobaleda J, Piñas B, Carrillo JA, Benitez J. Spina E, et al. Eur J Clin Pharmacol. 1991;41(5):467-70. doi: 10.1007/BF00626371. Eur J Clin Pharmacol. 1991. PMID: 1684751
Ethnic differences in drug disposition and responsiveness.
Wood AJ, Zhou HH. Wood AJ, et al. Clin Pharmacokinet. 1991 May;20(5):350-73. doi: 10.2165/00003088-199120050-00002. Clin Pharmacokinet. 1991. PMID: 1879095 Review.
Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer.
Horai Y, Fujita K, Ishizaki T. Horai Y, et al. Eur J Clin Pharmacol. 1989;37(6):581-7. doi: 10.1007/BF00562549. Eur J Clin Pharmacol. 1989. PMID: 2612554
Effect of liver disease on dextromethorphan oxidation capacity and phenotype: a study in 107 patients.
Larrey D, Babany G, Tinel M, Freneaux E, Amouyal G, Habersetzer F, Letteron P, Pessayre D. Larrey D, et al. Br J Clin Pharmacol. 1989 Sep;28(3):297-304. doi: 10.1111/j.1365-2125.1989.tb05430.x. Br J Clin Pharmacol. 1989. PMID: 2789923 Free PMC article.
Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients.
Watkins PB, Murray SA, Winkelman LG, Heuman DM, Wrighton SA, Guzelian PS. Watkins PB, et al. J Clin Invest. 1989 Feb;83(2):688-97. doi: 10.1172/JCI113933. J Clin Invest. 1989. PMID: 2913056 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

Grants and funding

GM 31304/GM/NIGMS NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information